EU Politics

World

A New Axis Emerges: Meloni and Merz Forge Conservative Alliance, Diminishing Macron's Role in EU Leadership

Italian Prime Minister Giorgia Meloni and German Chancellor Friedrich Merz have signed a landmark partnership pact in Rome, signaling a potential shift in the European Union's traditional Franco-German power center. The accord, focusing on defense, migration, and trade, comes as France grapples with political instability and a weakened presidency.

Feb 2, 2026

Business

Travere Therapeutics Under Investigation: Legal Scrutiny Clouds Biotech's Path to Profitability

Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.

Feb 2, 2026

Business

Beyond the Headlines: Three European Small-Caps Poised for Growth in February 2026

Amid a patchy eurozone recovery, investors are scanning the market's fringes for potential. We spotlight three small-cap stocks from Norway and Sweden, each navigating unique challenges while showing flashes of promise for the discerning, risk-tolerant investor.

Feb 2, 2026

Business

DeFi Giants Unwind: $371 Million Ethereum Sell-Off Signals Strategic Risk Reduction

Two of the largest known Ethereum holders, BitcoinOG and Trend Research, have strategically sold a combined $371 million worth of ETH to repay loans on the Aave protocol. This voluntary deleveraging, distinct from over $140 million in automated liquidations processed by Aave, highlights a shift towards caution among major crypto players amid market volatility.

Feb 2, 2026

Business

Insider Bets Signal Hidden Gems: Three European Small-Caps Poised for a Rebound

Amidst a patchy economic recovery, European small-cap stocks are back in focus. A surge in insider buying activity points to potential undervaluation in select names across property, cybersecurity, and defense tech sectors.

Feb 2, 2026

Business

Bargain Hunt: Three European Stocks Trading Below Their True Worth in February 2026

Amid a patchy market recovery, savvy investors are scouring Europe for hidden gems. We spotlight three companies—from shipping to sportswear—whose current share prices appear significantly discounted against their intrinsic value, presenting potential opportunities for long-term growth.

Feb 2, 2026

Business

Insider Bets: Three European Growth Stocks Where Management Has Skin in the Game

As confidence in the Eurozone's recovery builds, investors are scrutinizing companies where executives hold significant equity stakes—a potential signal of alignment and long-term conviction. We spotlight three firms from a broader screen of 220 high-insider-ownership growth stocks.

Feb 2, 2026

Business

Beyond the Blue Chips: Three European Undiscovered Gems Poised for Growth

Amidst a cautiously recovering Eurozone economy, we spotlight three lesser-known European companies—spanning finance, telecom, and food production—that combine strong fundamentals with compelling growth narratives for discerning investors.

Feb 2, 2026

Business

Seeking Stability: European Dividend Stocks Gain Appeal Amid Market Uncertainty

As Europe's markets navigate a fragile recovery, investors are turning to dividend-paying stocks for income and resilience. We examine three companies offering attractive yields, weighing their potential against underlying financial risks.

Feb 2, 2026

World

Iran Escalates Rhetoric, Labels EU Armies as 'Terrorists' Amid Rising US Tensions

Iran's Supreme Leader warns of a broader regional war if the US launches an attack, as Tehran retaliates against the EU's terrorist designation of the Revolutionary Guards by branding European armies similarly. The moves come amidst a significant US naval buildup and fragile diplomatic signals.

Feb 2, 2026

Business

Perspective Therapeutics Surges on Promising Cancer Trial Data, But Valuation Gap Raises Questions

Shares of Perspective Therapeutics (CATX) have rallied sharply following encouraging interim results from its lead cancer therapy trial and a strategic business update. While the data fuels optimism, a deep dive into the numbers reveals a stark disconnect between its current market price and analyst targets, highlighting both opportunity and significant risk.

Feb 2, 2026

Business

Euro's Surge Casts Shadow Over ECB Policy Meeting

The European Central Bank convenes this week with a resurgent euro presenting a fresh dilemma, threatening to dampen inflation and undermine the export engine of the eurozone's largest economies just as recovery gains momentum.

Feb 2, 2026

Business

Archer Aviation Lands Strategic Deal with Serbia, Eyes European eVTOL Market Ahead of EXPO 2027

Archer Aviation secures a pivotal agreement with Serbia to supply its electric air taxis for EXPO 2027, marking a significant step into the European market and sparking discussions on its path to commercialization and valuation.

Feb 2, 2026

Business

Definium Therapeutics Bolsters Board with Commercial Veteran Roger Adsett Ahead of Pivotal Trials

Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.

Jan 31, 2026

Business

Tilray Bets on Italy: A New Medical Cannabis Unit Aims to Anchor European Growth

Tilray Brands deepens its commitment to Europe's regulated medical cannabis sector with the launch of Tilray Medical Italia, a strategic venture with local partner Molteni Farmaceutici. The move comes as the company seeks to stabilize its growth narrative amid significant stock market volatility.

Jan 31, 2026

Business

Occidental Petroleum's Stock Surge and Carbon Capture Ambitions Spark Valuation Debate

Shares of Occidental Petroleum (OXY) have rallied roughly 10% over the last quarter, reigniting investor interest. As the oil giant aggressively pursues its Direct Air Capture ventures, analysts are divided on whether the current price of $45.39 reflects its true worth or overlooks significant long-term potential.

Jan 31, 2026

Business

Day One Biopharmaceuticals: Surging Momentum Raises Valuation Questions Amid High-Stakes Pipeline

Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) have surged over 50% in the last three months, reigniting debate over its fair value and the risks tied to its lead drug OJEMDA and a pivotal upcoming data readout.

Jan 31, 2026

Business

Weyerhaeuser Navigates Brutal Lumber Markets, Bets on Land and Climate for Growth

Despite posting a quarterly loss in its core wood products unit amid 'extremely challenging' markets, Weyerhaeuser closed 2025 with strategic pivots. The forestry giant is doubling down on its land management and nascent 'Climate Solutions' business, while managing a disciplined capital return to shareholders.

Jan 31, 2026

Business

WisdomTree Hits Record $160.8B AUM, Driven by European Surge and Digital Asset Growth

WisdomTree Investments capped off a transformative 2025 with record assets under management, fueled by a landmark European expansion and a burgeoning digital assets platform. The firm's strategic acquisition of Ceres Partners has also opened a new frontier in private markets, setting the stage for continued margin growth in 2026.

Jan 31, 2026

Business

Coeur Mining Clears Final Hurdle, Set to Absorb New Gold in Major North American Metals Consolidation

Coeur Mining's acquisition of New Gold has received final court approval in British Columbia, marking a pivotal step toward creating a larger, diversified precious metals producer. The deal is poised to reshape the competitive landscape for mid-tier gold and silver miners in North America.

Jan 31, 2026